nach oben

Reactions Weekly

Erschienen in:

01.05.2023 | Case report

Acarbose/octreotide

Gastrointestinal side effects and relentless constipation: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

May A, et al. Abstract #1413680: Post-Bariatric Hypoglycemia (PBH) Refractory to Conventional Therapies: The Combined Effect of Very High Doses of Glucagon-Like Receptor Agonist (GLP1-RA) and a Low Dose of Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i). Endocrine Practice 29 (Suppl.): S29, No. 5, May 2023. Available from: URL: http://doi.org/10.1016/j.eprac.2023.03.068 [abstract]

Titel: Acarbose/octreotide
Gastrointestinal side effects and relentless constipation: case report
Publikationsdatum: 01.05.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-38628-1

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Acarbose/octreotide

Gastrointestinal side effects and relentless constipation: case report

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Bleomycin

Gabapentin/nonsteroidal-anti-inflammatories/steroids

Drospirenone/ethinylestradiol

Dexamethasone/heparin/insulin

Cabozantinib/pembrolizumab

Ascorbic-acid overdose